Burger JA - Search Results

1

CXCR4 chemokine receptor antagonists: perspectives in SCLC.

Burger JA, Stewart DJ. Burger JA, et al. Expert Opin Investig Drugs. 2009 Apr;18(4):481-90. doi: 10.1517/13543780902804249. Expert Opin Investig Drugs. 2009. PMID: 19335276 Review.

2

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

Burger JA, Kipps TJ. Burger JA, et al. Blood. 2006 Mar 1;107(5):1761-7. doi: 10.1182/blood-2005-08-3182. Epub 2005 Nov 3. Blood. 2006. PMID: 16269611 Free article. Review.

3

The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.

Burger JA, Bürkle A. Burger JA, et al. Br J Haematol. 2007 May;137(4):288-96. doi: 10.1111/j.1365-2141.2007.06590.x. Br J Haematol. 2007. PMID: 17456052 Free article. Review.

4

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.

Burger JA, Peled A. Burger JA, et al. Leukemia. 2009 Jan;23(1):43-52. doi: 10.1038/leu.2008.299. Epub 2008 Nov 6. Leukemia. 2009. PMID: 18987663 Review.

5

Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.

Kurtova AV, Tamayo AT, Ford RJ, Burger JA. Kurtova AV, et al. Among authors: burger ja. Blood. 2009 May 7;113(19):4604-13. doi: 10.1182/blood-2008-10-185827. Epub 2009 Feb 19. Blood. 2009. PMID: 19228923 Free PMC article.

6

Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.

Niedermeier M, Hennessy BT, Knight ZA, Henneberg M, Hu J, Kurtova AV, Wierda WG, Keating MJ, Shokat KM, Burger JA. Niedermeier M, et al. Among authors: burger ja. Blood. 2009 May 28;113(22):5549-57. doi: 10.1182/blood-2008-06-165068. Epub 2009 Mar 24. Blood. 2009. PMID: 19318683 Free PMC article.

7

B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG, Gandhi V, Burger JA. Quiroga MP, et al. Among authors: burger ja. Blood. 2009 Jul 30;114(5):1029-37. doi: 10.1182/blood-2009-03-212837. Epub 2009 Jun 2. Blood. 2009. PMID: 19491390 Free PMC article.

8

The microenvironment in mature B-cell malignancies: a target for new treatment strategies.

Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. Burger JA, et al. Blood. 2009 Oct 15;114(16):3367-75. doi: 10.1182/blood-2009-06-225326. Epub 2009 Jul 27. Blood. 2009. PMID: 19636060 Free PMC article. Review.

9

Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting.

Burger JA. Burger JA. Semin Cancer Biol. 2010 Dec;20(6):424-30. doi: 10.1016/j.semcancer.2010.09.005. Epub 2010 Sep 29. Semin Cancer Biol. 2010. PMID: 20883788 Review.

10

Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia.

Konoplev S, Jorgensen JL, Thomas DA, Lin E, Burger J, Kantarjian HM, Andreeff M, Medeiros LJ, Konopleva M. Konoplev S, et al. Cancer. 2011 Oct 15;117(20):4689-95. doi: 10.1002/cncr.26113. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456010 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters